Semaglutide Reconstitution Guide: Dosing, Mixing & Storage

Semaglutide is arguably the most talked-about peptide in modern research. As a GLP-1 receptor agonist with a uniquely long half-life, it’s the compound behind several landmark clinical trials in metabolic research. But if you’re working with lyophilized semaglutide powder, the reconstitution and dosing math can be intimidating — especially with the weekly titration schedule that most protocols follow.

This guide walks through everything: what semaglutide is, how to reconstitute it properly, how to calculate exact doses at each titration step, and how to store your reconstituted solution for maximum stability.

Quick Summary

• Peptide type: GLP-1 receptor agonist (modified analog of human GLP-1)
• Common vial size: 5 mg lyophilized powder
• Typical research doses: 0.25 mg–2.4 mg weekly (titrated upward)
• Reconstitute with: Bacteriostatic water
• Storage after reconstitution: 2–8°C (refrigerated) for up to 56 days
• Half-life: ~7 days (supports once-weekly dosing)
• Route: Subcutaneous injection
• Use our Peptide Reconstitution Calculator for instant dosing math

What Is Semaglutide?

Semaglutide is a synthetic analog of human glucagon-like peptide-1 (GLP-1). Native GLP-1 is an incretin hormone released by the gut after eating — it stimulates insulin secretion, suppresses glucagon, slows gastric emptying, and acts on appetite centers in the brain.

The problem with native GLP-1 is that it’s degraded within minutes by the enzyme DPP-4 and cleared by the kidneys. Semaglutide solves this through three key structural modifications:

• Amino acid substitution at position 8 (Aib replaces Ala) — resists DPP-4 cleavage
• C-18 fatty diacid chain attached via a linker at position 26 — enables albumin binding in the bloodstream
• Additional minor modifications that improve receptor affinity

The result is a peptide with a half-life of approximately 7 days — roughly 1,000 times longer than native GLP-1. This extended half-life is what makes once-weekly dosing practical.

Why Semaglutide Matters in Research

Semaglutide has been studied in some of the largest peptide clinical trial programs ever conducted. Key areas of research include:

• Metabolic research — body weight regulation, appetite signaling, energy expenditure
• Glycemic control — insulin sensitivity, beta-cell function
• Cardiovascular research — reduction in major adverse cardiovascular events (MACE)
• Neuroscience — emerging research on neuroinflammation and neurodegeneration
• Hepatology — non-alcoholic steatohepatitis (NASH) and liver fat reduction

How Semaglutide Is Supplied

For research purposes, semaglutide is typically supplied as a lyophilized (freeze-dried) powder in glass vials. The most common configuration:

• 5 mg per vial — the standard research size
• 10 mg per vial — available from some suppliers for higher-volume protocols

The powder appears as a white to off-white cake or loose powder. Before reconstitution, lyophilized semaglutide should be stored frozen at -20°C for long-term stability, or refrigerated at 2–8°C for shorter-term storage (up to several months).

How to Reconstitute Semaglutide

What You’ll Need

• Semaglutide vial (5 mg example used throughout this guide)
• Bacteriostatic water (BAC water with 0.9% benzyl alcohol)
• 1 mL insulin syringe for adding water
• 0.5 mL or 0.3 mL insulin syringe for dosing
• Alcohol swabs

Choosing Your Water Volume

The amount of bacteriostatic water you add determines your solution concentration. Because semaglutide doses are measured in milligrams (not micrograms like many peptides), the math works a bit differently.

For a 5 mg vial:

Recommended: 2 mL of BAC water into a 5 mg vial. This gives you 2.5 mg/mL, which puts the most common doses at clean syringe volumes and leaves enough solution for a full titration cycle.

Step-by-Step Reconstitution

1. Remove the plastic flip-off cap from the semaglutide vial
2. Swab both vial stoppers (peptide and BAC water) with alcohol. Let air dry for 10 seconds
3. Draw 2 mL of bacteriostatic water into a syringe. You may need to fill a 1 mL syringe twice
4. Insert the needle through the rubber stopper of the semaglutide vial
5. Aim the needle at the glass wall — not directly at the powder cake
6. Depress the plunger slowly over 30–60 seconds. Let the water trickle down the side of the vial. This gentle approach prevents peptide degradation from turbulence
7. Withdraw the needle and place the vial on a flat surface
8. Swirl gently with slow circular movements. Do not shake — shaking can damage the peptide through shear forces
9. Wait 2–5 minutes. Semaglutide dissolves well but may take slightly longer than simpler peptides
10. Inspect. The solution should be clear and colorless. Cloudiness or visible particles after 10 minutes of gentle swirling suggests a problem — do not use

For a complete walkthrough of reconstitution technique, see our step-by-step peptide mixing guide.

Semaglutide Dosing: The Titration Schedule

Unlike peptides that use a fixed dose from the start, semaglutide research protocols use a gradual titration schedule. The purpose is to allow adaptation and minimize gastrointestinal side effects (nausea, in particular) that can occur with GLP-1 agonists.

Standard Weekly Titration Protocol

Not all protocols go to 2.4 mg. Many research applications use 1.0 mg or 1.7 mg as the maintenance dose, depending on the study objectives.

Worked Dosing Example

Let’s calculate exact syringe volumes for a 5 mg vial reconstituted with 2 mL BAC water:

Concentration: 5 mg ÷ 2 mL = 2.5 mg/mL (equivalent to 2,500 mcg/mL)

Total volume available: 2 mL = 200 units on an insulin syringe

• 0.25 mg dose: 0.25 ÷ 2.5 = 0.1 mL = 10 units
• 0.5 mg dose: 0.5 ÷ 2.5 = 0.2 mL = 20 units
• 1.0 mg dose: 1.0 ÷ 2.5 = 0.4 mL = 40 units
• 1.7 mg dose: 1.7 ÷ 2.5 = 0.68 mL = 68 units
• 2.4 mg dose: 2.4 ÷ 2.5 = 0.96 mL = 96 units

How many doses per vial? At 0.25 mg/week, a 5 mg vial provides 20 weeks of dosing. At 2.4 mg/week, the same vial lasts just over 2 weeks. Most researchers plan for the full titration when ordering.

Not sure about reading syringe units? Our guide breaks it down clearly.

Semaglutide Storage After Reconstitution

Proper storage is critical. Semaglutide’s modified structure gives it good stability, but poor storage will still degrade the peptide.

Storage Guidelines

• Reconstituted semaglutide: Refrigerate at 2–8°C (standard refrigerator temperature)
• Stability window: Up to 56 days (8 weeks) after reconstitution when stored properly
• Never freeze reconstituted solution — ice crystal formation can damage the peptide structure
• Protect from light — store in the original vial and keep away from direct light
• Unreconstituted powder: Freezer (-20°C) for long-term, or refrigerator for months

The 56-day stability window is notably longer than many peptides (which typically last 21–28 days). This is a direct benefit of semaglutide’s structural modifications, particularly the fatty acid chain that stabilizes the molecule.

For more on peptide storage best practices, see our complete peptide storage guide.

Signs of Degradation

Discard your solution if you observe:

• Cloudiness or turbidity
• Visible particles or precipitate
• Color change (should remain colorless)
• Solution has been left at room temperature for more than a few hours

Injection Guidance

Semaglutide is administered via subcutaneous injection — the same route used in all major clinical trials. For research protocols:

• Injection sites: Abdomen (most common), outer thigh, back of upper arm
• Rotate injection sites to prevent localized tissue reactions
• Inject at the same time each week — consistency matters for pharmacokinetic stability
• Use insulin syringes (29–31 gauge) for comfortable, precise delivery

Because semaglutide is dosed weekly, each injection may involve a relatively larger volume compared to peptides dosed daily. At the 2.4 mg dose (96 units with 2 mL reconstitution), the injection volume approaches 1 mL. If this is uncomfortable, you can reconstitute with less water (e.g., 1 mL instead of 2 mL) to halve the injection volume.

For injection technique details, see our subcutaneous injection guide.

Semaglutide vs. Other GLP-1 Peptides

Semaglutide isn’t the only GLP-1 agonist available for research, but it has specific advantages:

For a detailed comparison of semaglutide and tirzepatide — including reconstitution differences — see our tirzepatide guide.

Practical Tips for Semaglutide Research

Plan your vials around the titration. A single 5 mg vial reconstituted at 2 mL provides approximately 3.75 mg of usable peptide (accounting for dead volume losses). Map out how many vials you’ll need for your full titration schedule before starting.

Use the right syringe for the dose. At low doses (0.25 mg = 10 units), a 0.3 mL insulin syringe gives better precision than a 1 mL syringe. At higher doses, switch to a 1 mL syringe for convenience.

Don’t skip titration steps. The gradual ramp-up isn’t optional — GLP-1 agonist protocols that start at full dose consistently show higher rates of nausea and gastrointestinal discomfort in research subjects.

Label your vials. Write the reconstitution date, concentration, and expiration date (56 days out) on the vial or a label. This seems basic but prevents dosing errors when handling multiple vials.

Calculate Your Exact Dose

The math above covers the most common scenario, but if you’re using a different vial size, water volume, or dose target, our calculator handles all of it automatically.

Try our free Peptide Reconstitution Calculator to calculate your exact semaglutide dosing.

This content is for educational and research purposes only. Semaglutide is a research compound. Always follow applicable regulations and consult with qualified professionals regarding research protocols.